EP3616675A1 - Storage container for a storage and dispensing station for medicaments - Google Patents
Storage container for a storage and dispensing station for medicaments Download PDFInfo
- Publication number
- EP3616675A1 EP3616675A1 EP18191874.9A EP18191874A EP3616675A1 EP 3616675 A1 EP3616675 A1 EP 3616675A1 EP 18191874 A EP18191874 A EP 18191874A EP 3616675 A1 EP3616675 A1 EP 3616675A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- section
- wall
- projections
- separating device
- storage container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 107
- 229940079593 drug Drugs 0.000 claims abstract description 76
- 238000012384 transportation and delivery Methods 0.000 claims abstract description 28
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 239000000428 dust Substances 0.000 abstract description 31
- 238000000926 separation method Methods 0.000 abstract description 7
- 230000008878 coupling Effects 0.000 description 8
- 238000010168 coupling process Methods 0.000 description 8
- 238000005859 coupling reaction Methods 0.000 description 8
- 230000008021 deposition Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0076—Medicament distribution means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B39/00—Nozzles, funnels or guides for introducing articles or materials into containers or wrappers
- B65B39/007—Guides or funnels for introducing articles into containers or wrappers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B5/00—Packaging individual articles in containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, jars
- B65B5/10—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles
- B65B5/101—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles by gravity
- B65B5/103—Filling containers or receptacles progressively or in stages by introducing successive articles, or layers of articles by gravity for packaging pills or tablets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B9/00—Enclosing successive articles, or quantities of material, e.g. liquids or semiliquids, in flat, folded, or tubular webs of flexible sheet material; Subdividing filled flexible tubes to form packages
- B65B9/02—Enclosing successive articles, or quantities of material between opposed webs
- B65B9/04—Enclosing successive articles, or quantities of material between opposed webs one or both webs being formed with pockets for the reception of the articles, or of the quantities of material
- B65B9/045—Enclosing successive articles, or quantities of material between opposed webs one or both webs being formed with pockets for the reception of the articles, or of the quantities of material for single articles, e.g. tablets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F11/00—Coin-freed apparatus for dispensing, or the like, discrete articles
- G07F11/005—Special arrangements for insuring that only one single article may be dispensed at a time
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F11/00—Coin-freed apparatus for dispensing, or the like, discrete articles
- G07F11/02—Coin-freed apparatus for dispensing, or the like, discrete articles from non-movable magazines
- G07F11/44—Coin-freed apparatus for dispensing, or the like, discrete articles from non-movable magazines in which magazines the articles are stored in bulk
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
- G07F17/0092—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for assembling and dispensing of pharmaceutical articles
Definitions
- the present invention relates to a storage container for a supply and dispensing station for pharmaceuticals.
- Modern blister machines such as those in the WO 2013/034504 A1 are disclosed, depending on the stage of expansion, several hundred supply and delivery stations for medicines. A plurality of medicament portions of a certain type of medicament are stored in each of these, and one or more medicament portions can be delivered on request. With the blister machines, the medicinal products stored in the supply and delivery stations are put together and blistered individually for the patient according to the medically prescribed times of intake.
- Corresponding supply and dispensing stations for dispensing one or more individual medicament portions are controlled to compile the medicament portions.
- a supply and delivery station is controlled, a single medicament portion is separated with a separating device and transferred to a guide device of the blister machine via a delivery opening.
- a dispensed medication portion possibly with the interposition of a collecting device, is fed to a packaging device, which blisters individual or several medicament portions in accordance with the medical requirements.
- the separating device used for separating medicament portions is usually designed in the shape of a circular cylinder and is formed in a corresponding guide space of the storage container.
- a plurality of drug channels are provided on the periphery of the separating device, via which drug portions of the dispensing opening in a bottom surface of the Storage container are fed.
- Protrusions are formed between the individual drug channels, which are formed in one piece with a main body of the separating device or can be detachably attached to it.
- the projections regularly have an arcuate circumferential surface which bears against an inner wall of the guide space in which the separating device is arranged (in the context of this application, the term “concern” does not mean that a Full area touches another, but that a small (ring) gap may be formed at least in sections). If one places a surrounding end around the outer lateral surfaces of the projections, a circle results, the radius of which is only slightly smaller than the radius of the receiving space. In the prior art (when the drug channels are neglected), the separating devices therefore have a circular base area.
- a large number of medicament portions are arranged in the storage containers for the storage and delivery stations.
- the separating device is rotated through a certain angle in order to feed a medicament portion arranged in a medicament channel to the delivery opening.
- the separating device rub against each other as well as against the components of the storage container during the separation. This leads to flaking of the drug portions and a kind of drug dust forms. This settles on all components of the storage container, including the wall of the guide section in which the separating device is arranged.
- the object is achieved according to the invention by a storage container according to claim 1.
- the storage container according to the invention for a storage and dispensing station for pharmaceutical portions comprises a housing enclosing a receiving space for pharmaceutical portions with a guide section and a bottom surface, an inner wall of the guide section defining a circular cylindrical guide space and wherein the bottom surface has a discharge opening.
- a separating device with a central axis of rotation is arranged in the guide section of the housing.
- the separating device comprises a central main section and a plurality of protrusions, each protrusion having two end sections and a central section and wherein a medicament channel is formed in each case between two end sections of adjacent projections.
- the projections can be flatter than the main body of the guide device, which supports the supply of the drug portions to the drug channels.
- the outer lateral surface is regularly formed in a circular arc (based on a central axis of rotation) and the projections therefore form (if the drug channels are neglected) a type of hollow cylinder, the outer lateral surface of which rests on the inner wall of the guide section.
- the projections are designed differently. It is provided according to the invention that the central sections of the projections are recessed with respect to at least one of the end sections and the at least one end section of each projection is designed in such a way that its outer surface rests on the wall of the guide section (in the context of this application the term " It is not expressed that a surface completely touches another, but that a narrow or small (ring) gap that enables rotation of the separating device is formed at least in sections, if necessary.
- the projections rest against the wall only with a small section (or are slightly spaced apart from it) and, if appropriate, are guided from or on the wall, it being provided according to the invention that it this section is an end section to which a drug channel connects.
- this section is an end section to which a drug channel connects.
- the central sections of the projections are "withdrawn” with respect to the end sections, that is, viewed radially, do not extend as far to the wall as at least one of the end sections of each projection.
- a (wider) gap is therefore provided between the wall and the middle section compared to the aforementioned end sections.
- the term “gap” in the middle sections merely means that the distance wall / lateral surface of the central section is greater than the distance wall / lateral surface of the end section. If the middle sections are arcuate, this means that the gap between the wall and the central section is designed like a segment of a hollow cylinder. Alternatively, the middle section can also be designed like a kind of secant with respect to the wall, as a result of which the gap would then have the shape of a circular segment.
- a corresponding design of the protrusions has the result that pharmaceutical dust which arises during the separation can trickle down through the gap in the area of the central sections and is thus quickly led to the floor surface, where it can be guided to a receiving opening in the floor surface if the floor surface is designed accordingly.
- the configuration of the projections according to the invention results in a reduced friction surface wall / separating device, the force to be used to rotate the separating device is lower. It is essential here that the force required to rotate the separating device in the guide section changes only slightly, even with increased drug dust formation, since less drug dust adheres to the wall. Since the force to be rotated changes only slightly when dust is formed, the separating device can be controlled or rotated more precisely. The likelihood of incorrect dispensing (for example due to poor alignment of a medicament channel at the dispensing opening) is reduced in the storage container according to the invention.
- the design of the projections according to the invention has a further considerable advantage. Although it is also unavoidable according to the invention that drug dust falls down in the area of the drug channels, the proportion of drug dust falling down in the channels is reduced in relation to the total amount of drug dust, so that less drug dust goes to (and through) the discharge opening in the Floor area. According to the invention, the entry of drug dust in the blister machines is thus avoided, which extends the time intervals between drug-dust-related cleaning and thus reduces the downtime of the blister machine.
- end sections are uniformly distributed in all the projections. If only one such end section is provided per projection, this means that these end sections (viewed from the axis of rotation) are always arranged on the right or left of the projection. Depending on the direction of rotation, the end sections lying against the wall (hereinafter briefly “projecting” end sections; “projecting” with respect to the central section) are then arranged “at the rear” or “at the front” on the projection.
- both end sections of a projection are designed such that they abut the wall of the guide section.
- Appropriate training improves the delivery of a drug portion into the drug channel. The cleaning described above is then no longer possible, but a low-friction rotation of the separating device and a reduction in the entry of drug dust into the drug channels are still guaranteed.
- the end sections of the projections resting on the wall of the guide section regardless of whether one or both projections are designed accordingly, are distributed symmetrically over the separating device. If three drug channels and thus three projections are provided, this means that the drug channels are each offset by a central angle of 120 ° with respect to the axis of rotation.
- the projections have a non-stick coating at least in the area of the central section on a lateral surface facing the wall.
- the separating device has a conical surface with a plurality of recesses aligned with the drug channels.
- the main section has recesses above the drug channels.
- Figures 1a and 1b show two oblique views of a preferred first embodiment of the storage container 1 for a supply and dispensing station for pharmaceuticals.
- the storage container 1 according to the invention is part of the aforementioned storage and delivery station, the storage container usually being detachably arranged on a delivery station (not shown).
- a delivery station not shown.
- components can be arranged in the storage container or the delivery station.
- Figure 1b can be seen, which shows the storage container from below, in the embodiment shown it does not comprise a motor, but only a coupling piece 31, via which a separating device (shown in more detail in the following figures) can be coupled to a motor in the delivery station.
- the storage container 1 comprises a housing 10 with a circular cylindrical section 11, to which a bottom section 12 is connected at the bottom.
- the bottom section 12 is connected to the upper part of the housing via a handle 13 with which the storage container 1 can be removed from a corresponding delivery station.
- a circular recess 22 is arranged around the coupling piece 31, which is described in more detail in the following figures.
- FIGS. 2a and 2b show top views according to the first embodiment, wherein in both figures a cover 4 is omitted to illustrate the interior of the storage container.
- a separating device 40 is arranged in a receiving space defined by the circular cylindrical section 11 of the housing. This comprises a central main section 48 and a plurality of projections 42 arranged on the main section 48. These can be formed in one piece with the main section, but it is also possible that these are as releasable components can be fastened to the main section 48.
- a drug channel 41 is formed between each of two projections 42, via which drug portions arranged in the storage container Figure 2a shown) delivery channel 21 can be fed.
- the main section 48 of the separating device 40 comprises a conical surface 43 with four depressions 44, which are formed radially on the channels 41 and are intended to support the supply of drug portions to the drug channels.
- the projections are not designed as sections of a circular hollow cylinder, but are withdrawn or flattened in the central section (with respect to the axis of rotation), i.e. in these areas there is a gap between the projections and the inner wall of the circular cylindrical section 11 of the housing (the exact configuration of the projections in relation to the circular cylindrical section is described in more detail below).
- the plan view shown has also been omitted and the bottom surface 20 with a delivery opening 21 and a circular recess 22 can be seen.
- drug portions arranged in the drug channels 41 are delivered when a delivery channel is aligned with the delivery opening.
- the circular depression 22 is provided for receiving medicinal product dust that is produced when individualizing medicament portions.
- a coupling device 30 is arranged, via which the separating device can be coupled to a drive, which in the embodiment shown is not arranged in the storage container.
- the coupling device itself can be made in one piece with the separating device, but usually the separating device and the coupling device are detachably connected to one another, to enable the rapid replacement of the separating device without a coupling device.
- Figures 3a and 3b show an oblique view and a side view of a section through the first embodiment of the storage container according to the invention, whereby, as in particular Figure 3a it can be seen that the cut is carried out in such a way that it cuts through the separating device 40 between the drug channels 41.
- a gap is provided between an inner wall 3 of the circular cylindrical section 11 of the housing 10 and an outer circumferential surface 461 of a central section 46 of a projection 42, through which drug dust can trickle down onto the bottom surface 20 (the exact structure of the projections is given with reference described in the following figures).
- a slot is made in the area of the bottom opening 21 in the circular cylindrical section, through which a retaining section 51 of a retaining means 50 is inserted.
- the retention section prevents drug portions arranged above the drug channel when a drug channel is aligned at the delivery opening; only the drug portion contained in the channel when aligned is indicated.
- Figures 4a and 4b also show two sectional views, the section being orthogonal to that of FIGS Figures 3a and 3b is led. Also based on the Figures 4a and 4b it can be seen that a gap is formed between the inner wall 3 of the circular-cylindrical section 11 and a lateral surface 461 of the central section of a projection. Like it Figures 3a and 3b 4a and 4b can also be seen, the bottom surface 20 is designed to slope down towards the center and comprises a depression 22, so that drug dust trickling down the gap can get into the depression 22 via the falling bottom surface. Furthermore, the Figures 4a and 4b It can be seen that the lower surface 49 of the separating device is also formed obliquely, so that a gap is formed between the bottom surface 20 and the separating device, through which drug dust can reach the recess 22.
- the separating device comprises four channels 41, which are defined by four projections 42.
- the main body 48 extends beyond the projections 42, ie a circumferential recess is formed in the region of the projections, which supports the supply of the drug portions into the channels 41.
- the separating device 40 comprises a conical upper surface 43 with four recesses 44 which are aligned with the drug channels. Recesses 44a are formed in the main body 48 and are aligned with the depressions 44 and the drug channels 41 Wells 44 support the delivery of drug portions into the drug channels 41.
- the projections 42 each comprise two end sections 45 with lateral surfaces 451 and central sections 46 with lateral surfaces 461.
- the projections are not designed in the form of a circular arc with respect to the central axis of rotation, but that the central sections are withdrawn in this regard, ie the radius in the central sections is smaller than the radius in the end sections. This is explained in more detail with reference to the following figures.
- Figures 6a and 6b show the arrangement of the separating device 40 in the circular cylindrical guide space provided by the guide section 11 with the inner wall 3.
- the separating device comprises four channels 41 and four projections 42.
- the projections lie in the region of the end sections 45 with jacket surfaces 451 on the wall of the guide section 11, whereas a jacket surface 461 of a central section 46 of a projection does not abut the wall, but rather a gap is formed between the jacket surface and the wall. Via this gap, the drug dust produced during the separation can pass the separation device and onto the bottom surface of the storage container.
- the radius RMA that is to say the distance from the lateral surface to the central axis of rotation DA
- the middle sections 46 is greater than the radius RMI at the middle sections 46.
- Figure 8 shows a plan view of a second embodiment of a separating device, which is essentially designed in accordance with the first embodiment, with the exception that only three drug channels 41 are provided. The remaining versions correspond to the first embodiment.
- Figure 9 shows a third embodiment of the separating device, wherein also in this embodiment both end sections of a projection protrude from the central section, ie the radius RMA at the end sections 45 is greater than the radius RMI at the central sections 46.
- the central section is based on the central axis of rotation formed in a circular arc and rises gently in the transition area to the end sections.
- the middle section can also be formed by not being arch-shaped, but simply by forming a straight line between the end sections, which would lead to a gap with a different shape.
- Figure 10 shows a fourth embodiment of the separating device.
- this embodiment only one of the end sections of a projection protrudes with respect to the central section, ie only in one of the end sections is the radius RMA greater than the radius RMI of the central section.
- the “other” end section 47 is configured in exactly the same way as the central section, ie the lateral surface 471 is formed in the region corresponding to the lateral surface 461 of the central section.
- the separating device When separating drug portions, the separating device is rotated clockwise regularly in accordance with the embodiment shown, ie the projecting end sections run "in front" of a drug channel to the dispensing opening (that in the embodiment shown below the right drug channel is arranged). When rotating counterclockwise, the projecting end portions 45 run after the drug channels.
- the edges of the projecting end sections 45 formed in the illustrated embodiment are suitable at the transition from the end section / drug channel to detach drug dust adhering to the wall therefrom.
- the design of the projections according to the invention also ensures in all four embodiments that the friction between the separating device and the wall is reduced due to the reduced contact surface wall / lateral surface compared to storage containers according to the prior art.
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Basic Packing Technique (AREA)
Abstract
Die vorliegende Erfindung betrifft einen Vorratsbehälter für eine Vorrats- und Abgabestationen für Arzneimittel. Bei bekannten Vorrats- und Abgabestationen verursacht der sich bei der Vereinzelung bildende Arzneimittelstaub eine erhöhte Reibung zwischen Vereinzelungseinrichtung und Wandung der Vorrats- und Abgabestation. Um dies zu vermeiden, umfasst die Vorrats- und Abgabestation ein einen Aufnahmeraum (2) umschließendes Gehäuse (10) mit einem Führungsabschnitt (11), wobei eine innere Wandung (3) des Führungsabschnitts (11) einen kreiszylinderförmigen Führungsraum definiert und eine in dem Führungsabschnitt (11) des Gehäuses (10) angeordnete Vereinzelungseinrichtung (40) mit einer zentralen Drehachse (DA), wobei die Vereinzelungseinrichtung (40) einen Hauptabschnitt (48) und eine Mehrzahl von Vorsprüngen (42) aufweist, wobei jeder Vorsprung (42) zwei Endabschnitte (45) und einen Mittelabschnitt (46) aufweist und zwischen zwei Endabschnitten (45) benachbarter Vorsprünge jeweils ein Arzneimittelkanal (41) ausgebildet ist, wobei die Mittelabschnitte (46) der Vorsprünge (42) zurückgenommen sind und der Endabschnitt (45) jedes Vorsprungs (42) an der Wandung (3) des Führungsabschnitts (11) anliegt.The present invention relates to a storage container for a supply and dispensing station for pharmaceuticals. In known supply and delivery stations, the drug dust that forms during the separation causes an increased friction between the separation device and the wall of the supply and delivery station. In order to avoid this, the supply and delivery station comprises a housing (10) surrounding a receiving space (2) with a guide section (11), an inner wall (3) of the guide section (11) defining a circular-cylindrical guide space and one in the guide section (11) of the housing (10) arranged separating device (40) with a central axis of rotation (DA), the separating device (40) having a main section (48) and a plurality of projections (42), each projection (42) having two end sections (45) and a middle section (46) and between two end sections (45) of adjacent projections a drug channel (41) is formed, the middle sections (46) of the projections (42) being withdrawn and the end section (45) of each projection ( 42) abuts the wall (3) of the guide section (11).
Description
Die vorliegende Erfindung betrifft einen Vorratsbehälter für eine Vorrats- und Abgabestation für Arzneimittel.The present invention relates to a storage container for a supply and dispensing station for pharmaceuticals.
Moderne Blisterautomaten, wie sie beispielsweise in der
Zum Zusammenstellen der Arzneimittelportionen werden entsprechende Vorrats- und Abgabestationen zur Abgabe einer oder mehrerer vereinzelter Arzneimittelportionen angesteuert. Bei der Ansteuerung einer Vorrats- und Abgabestation wird mit einer Vereinzelungseinrichtung eine einzelne Arzneimittelportion separiert und über eine Abgabeöffnung einer Führungseinrichtung des Blisterautomaten übergeben. Mittels der Führungseinrichtung wird eine abgegebene Arzneimittelportion, ggf. unter Zwischenschaltung einer Sammeleinrichtung, einer Verpackungseinrichtung zugeführt, welche einzelne oder mehrere Arzneimittelportionen entsprechend den ärztlichen Vorgaben verblistert.Corresponding supply and dispensing stations for dispensing one or more individual medicament portions are controlled to compile the medicament portions. When a supply and delivery station is controlled, a single medicament portion is separated with a separating device and transferred to a guide device of the blister machine via a delivery opening. By means of the guiding device, a dispensed medication portion, possibly with the interposition of a collecting device, is fed to a packaging device, which blisters individual or several medicament portions in accordance with the medical requirements.
Die zur Vereinzelung von Arzneimittelportionen verwendete Vereinzelungseinrichtung ist üblicherweise kreiszylinderförmig ausgebildet und ist in einem entsprechenden Führungsraum des Vorratsbehälters ausgebildet. An dem Umfang der Vereinzelungseinrichtung ist eine Mehrzahl von Arzneimittelkanälen vorgesehen, über welche Arzneimittelportionen der Abgabeöffnung in einer Bodenfläche des Vorratsbehälters zugeführt werden. Zwischen den einzelnen Arzneimittelkanälen sind Vorsprünge ausgebildet, die einstückig mit einem Hauptkörper der Vereinzelungseinrichtung ausgebildet sind oder lösbar an diesem befestigbar sind. Bei Vorratsbehältern gemäß dem Stand der Technik weisen die Vorsprünge regelmäßig eine kreisbogenförmige Mantelfläche auf, die an einer inneren Wandung des Führungsraums, in welchem die Vereinzelungseinrichtung angeordnet ist, anliegen (im Rahmen dieser Anmeldung sei mit dem Begriff des "Anliegens" nicht ausgedrückt, dass eine Fläche vollumfänglich eine andere berührt, sondern dass ggf. zumindest abschnittsweise ein kleiner (Ring-) Spalt ausgebildet ist). Legt man eine Umgebende um die äußeren Mantelflächen der Vorsprünge, ergibt sich ein Kreis, dessen Radius lediglich geringfügig geringer als der Radius des Aufnahmeraumes ist. Die Vereinzelungseinrichtungen weisen bei dem Stand der Technik (bei Vernachlässigung der Arzneimittelkanäle) also eine kreisförmige Grundfläche auf.The separating device used for separating medicament portions is usually designed in the shape of a circular cylinder and is formed in a corresponding guide space of the storage container. A plurality of drug channels are provided on the periphery of the separating device, via which drug portions of the dispensing opening in a bottom surface of the Storage container are fed. Protrusions are formed between the individual drug channels, which are formed in one piece with a main body of the separating device or can be detachably attached to it. In the case of storage containers according to the state of the art, the projections regularly have an arcuate circumferential surface which bears against an inner wall of the guide space in which the separating device is arranged (in the context of this application, the term "concern" does not mean that a Full area touches another, but that a small (ring) gap may be formed at least in sections). If one places a surrounding end around the outer lateral surfaces of the projections, a circle results, the radius of which is only slightly smaller than the radius of the receiving space. In the prior art (when the drug channels are neglected), the separating devices therefore have a circular base area.
In den Vorratsbehältern für die Vorrats- und Abgabestationen sind jeweils eine Vielzahl von Arzneimittelportionen angeordnet. Bei der Vereinzelung einer Arzneimittelportion wird die Vereinzelungseinrichtung um einen bestimmten Winkel rotiert, um eine in einem Arzneimittelkanal angeordnete Arzneimittelportion der Abgabeöffnung zuzuführen. In Abhängigkeit von der Form der Arzneimittelportionen und der Anzahl der in dem Vorratsbehälter angeordneten Arzneimittelportionen reiben diese bei der Vereinzelung sowohl aneinander als auch an den Bauteilen des Vorratsbehälters. Dadurch kommt es zu Abplatzungen bei den Arzneimittelportionen und es bildet sich eine Art Arzneimittelstaub. Dieser setzt sich an sämtlichen Bauteilen des Vorratsbehälters ab, unter anderem auch an der Wandung des Führungsabschnitts, in welchem die Vereinzelungseinrichtung angeordnet ist.A large number of medicament portions are arranged in the storage containers for the storage and delivery stations. When a medicament portion is separated, the separating device is rotated through a certain angle in order to feed a medicament portion arranged in a medicament channel to the delivery opening. Depending on the shape of the drug portions and the number of drug portions arranged in the storage container, they rub against each other as well as against the components of the storage container during the separation. This leads to flaking of the drug portions and a kind of drug dust forms. This settles on all components of the storage container, including the wall of the guide section in which the separating device is arranged.
Aufgrund der Ablagerung des Arzneimittelstaubes, insbesondere an der Wandung des Führungsabschnittes, erhöht sich die Reibung zwischen den Mantelflächen der Vorsprünge und der Wandung, so dass für eine Rotation der Vereinzelungseinrichtung bei zunehmender Arzneimittelstaubablagerung eine erhöhte Kraft aufzubringen ist. Durch die ungleichmäßige, zur Rotation der Vereinzelungseinrichtung aufzuwendende Kraft ist es schwierig, die Vereinzelungseinrichtung präzise zu steuern, so dass es zu Fehlabgaben kommen kann, was zu fehlerhaften Zusammenstellungen von Arzneimittelportionen führen kann.Due to the deposition of the drug dust, in particular on the wall of the guide section, the friction between the lateral surfaces of the projections and the wall increases, so that the separation device rotates with increasing drug dust deposition an increased force has to be applied. Due to the uneven force to be used to rotate the separating device, it is difficult to control the separating device precisely, so that incorrect dispensing can occur, which can lead to incorrect combinations of medicament portions.
Es ist Aufgabe der vorliegenden Erfindung, einen Vorratsbehälter für Vorrats- und Abgabestationen bereitzustellen, bei dem solche fehlerhaften Abgaben vermieden werden.It is an object of the present invention to provide a storage container for supply and delivery stations, in which such incorrect deliveries are avoided.
Die Aufgabe wird erfindungsgemäß gelöst durch einen Vorratsbehälter nach Patentanspruch 1. Der erfindungsgemäße Vorratsbehälter für eine Vorrats- und Abgabestation für Arzneimittelportionen umfasst ein einen Aufnahmeraum für Arzneimittelportionen umschließendes Gehäuse mit einem Führungsabschnitt und einer Bodenfläche, wobei eine innere Wandung des Führungsabschnitts einen kreiszylinderförmigen Führungsraum definiert und wobei die Bodenfläche eine Abgabeöffnung aufweist. Bei dem erfindungsgemäßen Vorratsbehälter ist in dem Führungsabschnitt des Gehäuses eine Vereinzelungseinrichtung mit einer zentralen Drehachse angeordnet. Die Vereinzelungseinrichtung umfasst einen zentralen Hauptabschnitt und eine Mehrzahl von Vorsprüngen, wobei jeder Vorsprung zwei Endabschnitte und einen Mittelabschnitt aufweist und wobei zwischen zwei Endabschnitten benachbarter Vorsprünge jeweils ein Arzneimittelkanal ausgebildet ist.The object is achieved according to the invention by a storage container according to
Bezogen auf die Drehachse können die Vorsprünge flacher als der Hauptkörper der Führungseinrichtung ausgebildet sein, was die Zuführung der Arzneimittelportionen zu den Arzneimittelkanälen unterstützt. Gemäß dem Stand der Technik ist die äußere Mantelfläche regelmäßig kreisbogenförmig (bezogen auf eine zentrale Drehachse) ausgebildet und die Vorsprünge bilden daher (bei Vernachlässigung der Arzneimittelkanäle) eine Art Hohlzylinder, dessen äußere Mantelfläche an der inneren Wandung des Führungsabschnitts anliegt.Relative to the axis of rotation, the projections can be flatter than the main body of the guide device, which supports the supply of the drug portions to the drug channels. According to the prior art, the outer lateral surface is regularly formed in a circular arc (based on a central axis of rotation) and the projections therefore form (if the drug channels are neglected) a type of hollow cylinder, the outer lateral surface of which rests on the inner wall of the guide section.
Bei dem erfindungsgemäßen Vorratsbehälter sind die Vorsprünge anders ausgebildet. Es ist erfindungsgemäß vorgesehen, dass die Mittelabschnitte der Vorsprünge in Bezug auf zumindest einen der Endabschnitte zurückgenommen sind und der zumindest eine Endabschnitt jedes Vorsprungs derart ausgebildet ist, dass dessen Außenfläche an der Wandung des Führungsabschnitts anliegt (im Rahmen dieser Anmeldung sei mit dem Begriff des "Anliegens" nicht ausgedrückt, dass eine Fläche vollumfänglich eine andere berührt, sondern dass ggf. zumindest abschnittsweise ein eine Rotation der Vereinzelungseinrichtung ermöglichender schmaler bzw. kleiner (Ring-) Spalt ausgebildet ist) .In the storage container according to the invention, the projections are designed differently. It is provided according to the invention that the central sections of the projections are recessed with respect to at least one of the end sections and the at least one end section of each projection is designed in such a way that its outer surface rests on the wall of the guide section (in the context of this application the term " It is not expressed that a surface completely touches another, but that a narrow or small (ring) gap that enables rotation of the separating device is formed at least in sections, if necessary.
Anders als bei bekannten Vorratsbehältern ist es also erfindungsgemäß vorgesehen, dass die Vorsprünge nur mit einem kleinen Abschnitt an der Wandung anliegen (oder geringfügig von dieser beabstandet sind) und ggf. von bzw. an dieser geführt sind, wobei es erfindungsgemäß vorgesehen ist, dass es sich bei diesem Abschnitt um einen Endabschnitt handelt, an welchen sich ein Arzneimittelkanal anschließt. Bei dem erfindungsgemäßen Vorratsbehälter liegt also nur ein geringer Teil der Mantelfläche der Vorsprünge an der Wandung des Führungsabschnitts an, nämlich die Summe der vorgenannten Endabschnitte. Wesentlich ist, dass die Mittelabschnitte der Vorsprünge gegenüber den Endabschnitten "zurückgenommen" sind, sich also radial gesehen nicht so weit zu der Wandung erstrecken wie zumindest einer der Endabschnitte jedes Vorsprungs. Bei den Mittelabschnitten ist also, im Vergleich zu den vorgenannten Endabschnitten, ein (breiterer) Spalt zwischen der Wandung und dem Mittelabschnitt vorgesehen.In contrast to known storage containers, it is therefore provided according to the invention that the projections rest against the wall only with a small section (or are slightly spaced apart from it) and, if appropriate, are guided from or on the wall, it being provided according to the invention that it this section is an end section to which a drug channel connects. In the storage container according to the invention, therefore, only a small part of the lateral surface of the projections bears against the wall of the guide section, namely the sum of the aforementioned end sections. It is essential that the central sections of the projections are "withdrawn" with respect to the end sections, that is, viewed radially, do not extend as far to the wall as at least one of the end sections of each projection. In the middle sections, a (wider) gap is therefore provided between the wall and the middle section compared to the aforementioned end sections.
Wie dieser "Spalt" geometrisch genau ausgebildet ist, hängt von der Außenfläche des Mittelabschnitts ab. Im Rahmen dieser Erfindung ist mit dem Begriff des "Spalts" bei den Mittelabschnitten lediglich gemeint, dass der Abstand Wandung/Mantelfläche des Mittelabschnitts größer ist als der Abstand Wandung/Mantelfläche des Endabschnitts. Wenn die Mittelabschnitte bogenförmig ausgebildet sind, bedingt dies, dass der Spalt zwischen Wandung und Mittelabschnitt wie ein Segment eines Hohlzylinders ausgebildet ist. Alternativ kann der Mittelabschnitt in Bezug auf die Wandung auch wie eine Art Sekante ausgeführt sein, wodurch der Spalt dann eher die Form eines Kreissegmentes hätte.How this "gap" is geometrically accurate depends on the outer surface of the central section. In the context of this invention, the term “gap” in the middle sections merely means that the distance wall / lateral surface of the central section is greater than the distance wall / lateral surface of the end section. If the middle sections are arcuate, this means that the gap between the wall and the central section is designed like a segment of a hollow cylinder. Alternatively, the middle section can also be designed like a kind of secant with respect to the wall, as a result of which the gap would then have the shape of a circular segment.
Eine entsprechende Ausgestaltung der Vorsprünge hat zur Folge, dass bei der Vereinzelung entstehender Arzneimittelstaub im Bereich der Mittelabschnitte durch den Spalt herabrieseln kann und so rasch zur Bodenfläche geführt wird, wo dieser bei entsprechender Ausbildung der Bodenfläche zu einer Aufnahmeöffnung in der Bodenfläche geführt werden kann.A corresponding design of the protrusions has the result that pharmaceutical dust which arises during the separation can trickle down through the gap in the area of the central sections and is thus quickly led to the floor surface, where it can be guided to a receiving opening in the floor surface if the floor surface is designed accordingly.
Dass der Arzneimittelstaub "ungehindert" durch den Spalt zwischen Wandung und Mittelabschnitt des Vorsprungs fallen kann, hat zur Folge, dass sich weniger Arzneimittelstaub an der Wandung absetzt und festsetzt. In der Summe bedingt die erfindungsgemäße Ausgestaltung der Vorsprünge eine verminderte Reibfläche Wandung/Vereinzelungseinrichtung, die aufzuwendende Kraft zur Drehung der Vereinzelungseinrichtung ist geringer. Wesentlich ist hier, dass sich die Kraft, die zur Drehung der Vereinzelungseinrichtung in dem Führungsabschnitt notwendig ist, auch bei vermehrter Arzneimittelstaubbildung nur geringfügig ändert, da sich weniger Arzneimittelstaub an der Wandung festsetzt. Da die zur Drehung aufzuwendende Kraft sich bei Staubbildung nur geringfügig ändert, ist die Vereinzelungseinrichtung präziser zu steuern bzw. zu drehen. Die Wahrscheinlichkeit von Fehlabgaben (beispielsweise durch mangelhafte Ausrichtung eines Arzneimittelkanals an der Abgabeöffnung) ist bei dem erfindungsgemäßen Vorratsbehälter vermindert.The fact that the drug dust can fall "unhindered" through the gap between the wall and the central section of the projection means that less drug dust settles and adheres to the wall. In sum, the configuration of the projections according to the invention results in a reduced friction surface wall / separating device, the force to be used to rotate the separating device is lower. It is essential here that the force required to rotate the separating device in the guide section changes only slightly, even with increased drug dust formation, since less drug dust adheres to the wall. Since the force to be rotated changes only slightly when dust is formed, the separating device can be controlled or rotated more precisely. The likelihood of incorrect dispensing (for example due to poor alignment of a medicament channel at the dispensing opening) is reduced in the storage container according to the invention.
Die erfindungsgemäße Ausgestaltung der Vorsprünge hat einen weiteren erheblichen Vorteil. Zwar ist auch erfindungsgemäß nicht zu vermeiden, dass Arzneimittelstaub im Bereich der Arzneimittelkanäle herabfällt, jedoch ist der Anteil des in den Kanälen herabfallenden Arzneimittelstaubs bezogen auf die Gesamtmenge des Arzneimittelstaubes vermindert, so dass weniger Arzneimittelstaub zu der (und durch die) Abgabeöffnung in der Bodenfläche gelangt. Erfindungsgemäß wird damit der Eintrag von Arzneimittelstaub in den Blisterautomaten vermieden, was die Zeitintervalle zwischen Arzneimittelstaub-bedingten Reinigungen verlängert und somit die Stillstandzeit des Blisterautomaten verringert.The design of the projections according to the invention has a further considerable advantage. Although it is also unavoidable according to the invention that drug dust falls down in the area of the drug channels, the proportion of drug dust falling down in the channels is reduced in relation to the total amount of drug dust, so that less drug dust goes to (and through) the discharge opening in the Floor area. According to the invention, the entry of drug dust in the blister machines is thus avoided, which extends the time intervals between drug-dust-related cleaning and thus reduces the downtime of the blister machine.
Bedingt durch die Form der Vorsprünge weisen diese stets zwei Endabschnitte auf, wobei jeder dieser Endabschnitte an einen Arzneimittelkanal grenzt. Zumindest einer dieser Endabschnitte liegt an der Wandung des Führungsabschnitts an, hat also einen größeren "Radius" als der zurückgenommene Mittelabschnitt. Wie genau der zweite Endabschnitt ausgebildet ist, ist für das Funktionieren der Erfindung nicht wesentlich. Wesentlich ist vielmehr, dass an der Wandung anliegende Endabschnitte eine gleichmäßige und schlagfreie, reibungsarme Rotation der Vereinzelungseinrichtung in dem Führungsabschnitt erlauben, was regelmäßig bei drei entsprechenden Endabschnitten der Fall ist (ggf. auch bereits bei zwei Endabschnitten, wenn diese entsprechend breit sind).Due to the shape of the projections, these always have two end sections, each of these end sections bordering a drug channel. At least one of these end sections bears against the wall of the guide section, that is to say it has a larger "radius" than the recessed central section. How exactly the second end section is formed is not essential for the functioning of the invention. Rather, it is essential that end sections lying against the wall allow a uniform and impact-free, low-friction rotation of the separating device in the guide section, which is regularly the case with three corresponding end sections (possibly also with two end sections if these are correspondingly wide).
Wie oben dargelegt, kommt es auch bei dem erfindungsgemäßen Vorratsbehälter zu Ablagerungen von Arzneimittelstaub. Bei einer bevorzugten Ausführungsform ist es daher vorgesehen, dass die Endabschnitte, deren Außenflächen an der Wandung des Führungsabschnitts anliegen, bei sämtlichen Vorsprüngen einheitlich verteilt sind. Wenn pro Vorsprung nur ein solcher Endabschnitt vorgesehen ist, bedeutet dies, dass diese Endabschnitte (von der Drehachse aus betrachtet) stets rechts oder links an dem Vorsprung angeordnet sind. In Abhängigkeit von der Drehrichtung sind die an der Wandung anliegenden Endabschnitte (nachfolgend kurz "vorspringende" Endabschnitte; "vorspringend" in Bezug auf den Mittelabschnitt) dann "hinten" oder "vorne" an dem Vorsprung angeordnet. Im "normalen" Vereinzelungsbetrieb ist die Drehrichtung regelmäßig so gewählt, dass die vorspringenden Endabschnitte "hinten" liegen, d. h. ein Arzneimittelkanal einem Endabschnitt nachfolgt. Dreht man die Drehrichtung, liegen die Endabschnitte bei den Vorsprüngen "vorne", folgen also einem Arzneimittelkanal in Drehrichtung nach.As stated above, drug dust is also deposited in the storage container according to the invention. In a preferred embodiment it is therefore provided that the end sections, the outer surfaces of which bear against the wall of the guide section, are uniformly distributed in all the projections. If only one such end section is provided per projection, this means that these end sections (viewed from the axis of rotation) are always arranged on the right or left of the projection. Depending on the direction of rotation, the end sections lying against the wall (hereinafter briefly “projecting” end sections; “projecting” with respect to the central section) are then arranged “at the rear” or “at the front” on the projection. In "normal" separating operation, the direction of rotation is regularly selected so that the projecting end sections are "behind", ie a drug channel follows an end section. If you turn the direction of rotation, the end sections are at the projections "in front", follow a drug channel in the direction of rotation.
Dies eröffnet die Möglichkeit, mit der erfindungsgemäßen Ausführungsform eine Reinigung der Wandung des Führungsabschnitts vorzunehmen, und zwar indem man die Vereinzelungseinrichtung kurzfristig derart dreht, dass die vorspringenden Endabschnitte "vorne" liegen. Bei entsprechender Ausbildung der Endabschnitte kann dann mit der vorderen Kante der Endabschnitte anhaftender Arzneimittelstaub von der Wandung entfernt werden. Dieser fällt dann durch die Kanäle auf die Bodenfläche.This opens up the possibility of using the embodiment according to the invention to clean the wall of the guide section, namely by briefly rotating the separating device in such a way that the projecting end sections are “in front”. If the end sections are designed appropriately, drug dust adhering to the front edge of the end sections can then be removed from the wall. This then falls through the channels onto the floor surface.
Bei einer alternativen bevorzugten Ausführungsform ist es vorgesehen, dass beide Endabschnitte eines Vorsprungs derart ausgebildet sind, dass sie an der Wandung des Führungsabschnitts anliegen. Eine entsprechende Ausbildung verbessert die Zuführung einer Arzneimittelportion in den Arzneimittelkanal. Zwar ist dann das oben beschriebene Reinigen nicht mehr möglich, eine reibungsarme Drehung der Vereinzelungseinrichtung und eine Verminderung des Eintrags von Arzneimittelstaub in die Arzneimittelkanäle ist aber weiter gewährleistet.In an alternative preferred embodiment, it is provided that both end sections of a projection are designed such that they abut the wall of the guide section. Appropriate training improves the delivery of a drug portion into the drug channel. The cleaning described above is then no longer possible, but a low-friction rotation of the separating device and a reduction in the entry of drug dust into the drug channels are still guaranteed.
Um eine besonders ruhige Drehung der Vereinzelungseinrichtung zu gewährleisten, ist es bei einer bevorzugten Ausführungsform vorgesehen, dass die an der Wandung des Führungsabschnitts anliegenden Endabschnitte der Vorsprünge, unabhängig davon ob ein oder beide Vorsprünge entsprechend ausgebildet sind, symmetrisch über die Vereinzelungseinrichtung verteilt sind. Sind drei Arzneimittelkanäle und damit drei Vorsprünge vorgesehen, bedeutet dies, dass die Arzneimittelkanäle bezogen auf die Drehachse jeweils um einen Mittelpunktswinkel von 120° versetzt sind.In order to ensure a particularly smooth rotation of the separating device, it is provided in a preferred embodiment that the end sections of the projections resting on the wall of the guide section, regardless of whether one or both projections are designed accordingly, are distributed symmetrically over the separating device. If three drug channels and thus three projections are provided, this means that the drug channels are each offset by a central angle of 120 ° with respect to the axis of rotation.
Um ein Anhaften von Arzneimittelstaub bei der Wandung des Mittelabschnitts der Vorsprünge zu vermeiden, ist es bei einer bevorzugten Ausführungsform vorgesehen, dass die Vorsprünge zumindest im Bereich des Mittelabschnitts bei einer der Wandung zugewandten Mantelfläche eine Antihaftbeschichtung aufweisen.In order to prevent drug dust from adhering to the wall of the central section of the projections, it is provided in a preferred embodiment that the projections have a non-stick coating at least in the area of the central section on a lateral surface facing the wall.
Um zu vermeiden, dass Arzneimittelportionen auf dem Hauptkörper der Vereinzelungseinrichtung liegen bleiben und zur Unterstützung der Zuführung von Arzneimittelportionen in die Arzneimittelkanäle, ist es bei einer bevorzugten Ausführungsform vorgesehen, dass die Vereinzelungseinrichtung eine konische Oberfläche mit einer Mehrzahl von an den Arzneimittelkanälen ausgerichteten Vertiefungen aufweist.In order to avoid that drug portions remain on the main body of the separating device and to support the supply of drug portions into the drug channels, it is provided in a preferred embodiment that the separating device has a conical surface with a plurality of recesses aligned with the drug channels.
Zur weiteren Unterstützung der Zuführung ist es darüber hinaus bevorzugt, dass der Hauptabschnitt oberhalb der Arzneimittelkanäle Rücksprünge aufweist.To further support the delivery, it is also preferred that the main section has recesses above the drug channels.
Nachfolgend werden bevorzugte Ausführungsformen des erfindungsgemäßen Vorratsbehälters für Vorrats- und Abgabestationen unter Bezugnahme auf die beigefügte Zeichnung beschrieben, in welcher
-
Figuren 1a und 1b verschiedene Schrägansichten einer ersten bevorzugten Ausführungsform des erfindungsgemäßen Vorratsbehälters zeigen; -
Figuren 2a und 2b Draufsichten der ersten erfindungsgemäßen Ausführungsform zeigen; -
Figuren 3a und 3b zwei Schnittansichten der ersten Ausführungsform zeigen; -
Figuren 4a und 4b ebenfalls zwei Schnittansichten, orthogonal zu den in denFiguren 3a und 3b dargestellten Schnittansichten, zeigen; -
Figuren 5a - 5f verschiedene Ansichten einer Vereinzelungseinrichtung der ersten Ausführungsform der erfindungsgemäßen Vorratsbehälter zeigen; -
Figuren 6a und 6b Draufsichten auf die Vereinzelungseinrichtung der ersten Ausführungsform zeigen; -
Figur 7 eine Detailansicht der Vereinzelungseinrichtung zeigt; -
Figur 8 eine Draufsicht einer Vereinzelungseinrichtung einer zweiten Ausführungsform zeigt; -
Figur 9 eine Draufsicht einer Vereinzelungseinrichtung einer dritten Ausführungsform zeigt; und -
eine Draufsicht einer Vereinzelungseinrichtung einer vierten Ausführungsform zeigt.Figur 10
-
Figures 1a and 1b show different oblique views of a first preferred embodiment of the storage container according to the invention; -
Figures 2a and 2b Top views of the first embodiment of the invention show; -
Figures 3a and 3b show two sectional views of the first embodiment; -
Figures 4a and 4b also two sectional views, orthogonal to the in theFigures 3a and 3b shown sectional views; -
Figures 5a - 5f show different views of a separating device of the first embodiment of the storage container according to the invention; -
Figures 6a and 6b Top views of the separating device of the first embodiment show; -
Figure 7 shows a detailed view of the separating device; -
Figure 8 shows a plan view of a separating device of a second embodiment; -
Figure 9 shows a plan view of a separating device of a third embodiment; and -
Figure 10 shows a plan view of a separating device of a fourth embodiment.
Der Vorratsbehälter 1 gemäß der ersten Ausführungsform umfasst ein Gehäuse 10 mit einem kreiszylinderförmigen Abschnitt 11, an welchen sich nach unten ein Bodenabschnitt 12 anschließt. Der Bodenabschnitt 12 ist mit dem oberen Teil des Gehäuses über einen Griff 13 verbunden, mit welchem der Vorratsbehälter 1 von einer entsprechenden Abgabestation genommen werden kann. Wie dies in
Die
Bei der in
Bei den
Wie es bei
Die
Wie es den
Im Detail dargestellt ist dies in
Bei der Vereinzelung von Arzneimittelportionen wird die Vereinzelungseinrichtung entsprechend der gezeigten Ausführungsform regelmäßig im Uhrzeigersinn gedreht, d. h. die vorspringenden Endabschnitte laufen "vor" einem Arzneimittelkanal auf die Abgabeöffnung zu (die bei der gezeigten Ausführungsform unter dem rechten Arzneimittelkanal angeordnet ist). Bei einer Drehbewegung gegen den Uhrzeigersinn laufen die vorspringenden Endabschnitte 45 den Arzneimittelkanälen nach. Die bei der dargestellten Ausführungsform ausgebildeten Kanten der vorspringenden Endabschnitte 45 sind bei dem Übergang Endabschnitt/Arzneimittelkanal geeignet, an der Wandung anhaftenden Arzneimittelstaub von dieser zu lösen. Mit einer entsprechend ausgebildeten Vereinzelungseinrichtung ist es daher möglich, durch kurzzeitige Drehbewegungen gegen den Uhrzeigersinn zumindest einen Teil des an der Wandung anhaftenden Arzneimittelstaubs von dieser zu lösen und der Bodenfläche und ggf. einer in dieser vorhandenen Vertiefung zuzuführen. Auf diese Weise kann eine übermäßige Ablagerung von Arzneimittelstaub auf der Wandung vermieden werden, ein stetes Ansteigen der Reibung zwischen Vereinzelungseinrichtung und Wandung wird vermieden.When separating drug portions, the separating device is rotated clockwise regularly in accordance with the embodiment shown, ie the projecting end sections run "in front" of a drug channel to the dispensing opening (that in the embodiment shown below the right drug channel is arranged). When rotating counterclockwise, the projecting
Durch die erfindungsgemäße Gestaltung der Vorsprünge wird bei allen vier Ausführungsformen ferner sichergestellt, dass die Reibung zwischen der Vereinzelungseinrichtung und der Wandung aufgrund der verkleinerten Kontaktfläche Wandung/Mantelfläche gegenüber Vorratsbehältern nach dem Stand der Technik vermindert ist.The design of the projections according to the invention also ensures in all four embodiments that the friction between the separating device and the wall is reduced due to the reduced contact surface wall / lateral surface compared to storage containers according to the prior art.
Claims (7)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18191874.9A EP3616675B1 (en) | 2018-08-31 | 2018-08-31 | Storage container for a storage and dispensing station for medicaments |
KR1020217005501A KR102694096B1 (en) | 2018-08-31 | 2019-05-24 | Storage containers for pharmaceutical storage and dispensing stations |
PCT/EP2019/063515 WO2020043334A1 (en) | 2018-08-31 | 2019-05-24 | Storage container for a storage and dispensing station for pharmaceuticals |
JP2021510868A JP7304938B2 (en) | 2018-08-31 | 2019-05-24 | Storage containers for pharmaceutical storage and dispensing stations |
CN201980056289.XA CN112638346B (en) | 2018-08-31 | 2019-05-24 | Storage container for a storage and dispensing station for pharmaceutical parts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18191874.9A EP3616675B1 (en) | 2018-08-31 | 2018-08-31 | Storage container for a storage and dispensing station for medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3616675A1 true EP3616675A1 (en) | 2020-03-04 |
EP3616675B1 EP3616675B1 (en) | 2021-04-14 |
Family
ID=63452479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18191874.9A Active EP3616675B1 (en) | 2018-08-31 | 2018-08-31 | Storage container for a storage and dispensing station for medicaments |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3616675B1 (en) |
JP (1) | JP7304938B2 (en) |
KR (1) | KR102694096B1 (en) |
CN (1) | CN112638346B (en) |
WO (1) | WO2020043334A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2227167A (en) * | 1939-07-14 | 1940-12-31 | Morton Salt Co | Dispenser for tablets |
WO2013034504A1 (en) | 2011-09-09 | 2013-03-14 | Carefusion Switzerland 317 Sàrl | System and method for packaging dosed quantities of solid drug portions |
EP2572995A1 (en) * | 2010-05-17 | 2013-03-27 | Yuyama Mfg. Co., Ltd. | Tablet cassette |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2572995A (en) * | 1946-03-26 | 1951-10-30 | Allen S Dunbar | Antenna |
TW557277B (en) * | 2001-09-30 | 2003-10-11 | Yuyama Mfg Co Ltd | Medicine packing apparatus |
US7516829B2 (en) * | 2002-04-25 | 2009-04-14 | Kite International Co., Ltd. | Vending machine of encapsulated article of commerce |
GB0315509D0 (en) * | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
DE102006027521B4 (en) * | 2006-06-10 | 2016-01-07 | Edwin Kohl | Plant for the personal placement of medication dispensers |
EP2543603A4 (en) * | 2010-03-01 | 2017-11-29 | Yuyama Mfg. Co., Ltd. | Powder removal device of medicine dispenser |
EP2703299B1 (en) * | 2012-08-31 | 2016-03-30 | CareFusion Switzerland 317 Sarl | A storage and dosing station for storage and dispensing dosed quantities of solid drug portions |
KR101449717B1 (en) * | 2013-01-02 | 2014-10-15 | 주식회사 인포피아 | Tablets cartridge for drug dispensing apparatus |
KR102083863B1 (en) | 2013-10-09 | 2020-03-03 | 가부시키가이샤 다카조노 테크놀로지 | Medicine filling device |
GB2531996B (en) * | 2014-10-20 | 2018-01-17 | Trig1 Ltd | Dispensing container with contents level indication |
EP3199141A1 (en) * | 2016-01-29 | 2017-08-02 | Becton Dickinson Rowa Germany GmbH | Storage container for a storage and dispensing station for medicaments |
TWI724134B (en) | 2016-03-25 | 2021-04-11 | 日商湯山製作所有限公司 | Rotor for tablet box and tablet box |
US10255524B2 (en) * | 2016-06-03 | 2019-04-09 | Becton Dickinson Rowa Germany Gmbh | Method for providing a singling device of a storage and dispensing container |
EP3358538B1 (en) * | 2017-02-03 | 2022-03-30 | Becton Dickinson Rowa Germany GmbH | Storage and dispensing station for a blister packaging machine |
US10380824B2 (en) * | 2017-02-03 | 2019-08-13 | Becton Dickinson Rowa Germany Gmbh | Storage and dispensing station for blister packaging machine |
-
2018
- 2018-08-31 EP EP18191874.9A patent/EP3616675B1/en active Active
-
2019
- 2019-05-24 WO PCT/EP2019/063515 patent/WO2020043334A1/en active Application Filing
- 2019-05-24 CN CN201980056289.XA patent/CN112638346B/en active Active
- 2019-05-24 KR KR1020217005501A patent/KR102694096B1/en active IP Right Grant
- 2019-05-24 JP JP2021510868A patent/JP7304938B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2227167A (en) * | 1939-07-14 | 1940-12-31 | Morton Salt Co | Dispenser for tablets |
EP2572995A1 (en) * | 2010-05-17 | 2013-03-27 | Yuyama Mfg. Co., Ltd. | Tablet cassette |
WO2013034504A1 (en) | 2011-09-09 | 2013-03-14 | Carefusion Switzerland 317 Sàrl | System and method for packaging dosed quantities of solid drug portions |
Also Published As
Publication number | Publication date |
---|---|
JP7304938B2 (en) | 2023-07-07 |
CN112638346B (en) | 2024-05-28 |
CN112638346A (en) | 2021-04-09 |
EP3616675B1 (en) | 2021-04-14 |
WO2020043334A1 (en) | 2020-03-05 |
KR20210049105A (en) | 2021-05-04 |
KR102694096B1 (en) | 2024-08-09 |
JP2022500103A (en) | 2022-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69732559T2 (en) | Machine for producing weakening lines on blister packs | |
EP2962956B1 (en) | Storage container for a device for the automated dispensing of individual medication portions | |
WO2021254739A1 (en) | Storage container for a storage and dispensing station | |
CH672600A5 (en) | ||
EP3389022A1 (en) | Storage container for a storage and dispensing station | |
EP3421381B1 (en) | Centering device | |
WO2018141497A1 (en) | Storage and dispensing station for a blister dispenser | |
WO2016113291A1 (en) | Packaging device for drugs | |
EP3616675B1 (en) | Storage container for a storage and dispensing station for medicaments | |
EP3463731B1 (en) | Cutting insert for a milling tool and milling tool | |
EP2242469B1 (en) | Blister pack assembly | |
WO2003037760A1 (en) | Device for separating drinks bottles with neck collars | |
DE2651723B2 (en) | Device for distributing a lining material in sheet metal bodies | |
WO2021254738A1 (en) | Storage container for a storage and dispensing station | |
WO2017129775A1 (en) | Storage container for a storage and dispensing station for pharmaceuticals | |
EP3527510A1 (en) | Separating device for separating crossed hooks | |
EP1682070B1 (en) | Machine for filling and closing two-part capsules | |
DE10132180A1 (en) | Machine for aligning capsules has sorting roller pivot-mounted on horizontal axle, with inner and outer periphery, and two stationary deflector elements | |
EP3926594A1 (en) | Storage container for a storage and dispensing station | |
DE3539345A1 (en) | DEVICE FOR STRAPING STICK-SHAPED COMPONENTS, IN PARTICULAR ELECTRICAL COMPONENTS (MELFS) | |
DE102007008047A1 (en) | Product e.g. tablet, supplying device for e.g. bowl, has releasing device controlling delivery of products and attached to stack shaft, where products are actuated in common and aligned manner | |
EP3879503A1 (en) | Storage and discharge station for medicines | |
EP4434903A1 (en) | Storage container for a storage and dispensing station for a blister machine and method for separating small piece goods | |
EP4067245A1 (en) | Storage and discharge station for a blister machine | |
WO2022089973A1 (en) | Storage vessel for a storage and dispensing station, and storage and dispensing station |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200626 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20210114 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502018004781 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1381646 Country of ref document: AT Kind code of ref document: T Effective date: 20210515 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210714 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210714 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210816 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210814 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210715 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502018004781 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20220117 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20210831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210831 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210814 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210831 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210831 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20180831 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230720 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230720 Year of fee payment: 6 Ref country code: DE Payment date: 20230720 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210414 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20240723 Year of fee payment: 7 |